Article
[Mutation Frequencies in RNAi Targets in HIV-1 Genomes Obtained from Blood Plasma of Patients Receiving Anti-Retroviral Therapy].
Molekuliarnaia biologiia - 1 Jan 2000
Kretova O V, Gorbacheva M A, Fedoseeva D M, Kravatskya Y V, Chechetkin V R, Tchurikov N A
Abstract excerpt
Gene therapy for AIDS based on RNA interference (RNAi) is currently looked upon as a promising alternative to conventional antiretroviral chemotherapy. The high variability of HIV-1 is the main challenge in developing new approaches to AIDS therapy. To date, about 18 million HIV-1 infected individuals receive antiretroviral therapy worldwide. As of 2017, about 44% of individuals with AIDS received antiretroviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
